MONTE ROSA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.33 USD | -2.20% |
|
-8.89% | -5.66% |
| 03-14 | Monte Rosa Therapeutics Q4 Net Loss Narrows; Shares Decline | MT |
| 03-14 | Monte Rosa Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Chart calendar Monte Rosa Therapeutics, Inc.
51211ee8c0b4a.TPiboCEDLpDlGytMr4FLri4iXjuP3cD3qoVfc-wW_Hk.FrntlkA7X8DXckoa8OoZ2EdXB1q8mZ-1mP0yGLN3rRYvqMzHE01j29ZBZg~308914a47fc4d081fa542b3cdafbc3eb
Upcoming events on Monte Rosa Therapeutics, Inc.
Past events on Monte Rosa Therapeutics, Inc.
| 14/03/2024 11:00 | Q4 2023 Earnings Release |
| 06/03/2024 14:10 | TD Cowen Health Care Conference |
| 07/02/2024 18:30 | Guggenheim Healthcare Talks Biotechnology Conference |
| 10/01/2024 23:00 | JPMorgan Healthcare Conference |
| 28/11/2023 20:30 | Piper Sandler Healthcare Conference |
| 13/11/2023 | Jefferies London Healthcare Conference |
| 12/11/2023 17:00 | American College of Rheumatology Conference - Abstract No: #0082 |
| 09/11/2023 12:00 | Q3 2023 Earnings Release |
| 03/11/2023 17:00 | TD Cowen Fall Oncology Innovation Summit - Fireside Chat |
| 17/10/2023 13:00 | MRT-2359 Phase 1/2 Trial Results Call |
| 10/08/2023 12:15 | Q2 2023 Earnings Release |
| 14/06/2023 13:30 | Annual General Meeting |
| 05/06/2023 18:00 | BIO International Convention |
| 11/05/2023 12:30 | Q1 2023 Earnings Release |
| 17/04/2023 19:30 | American Association for Cancer Research Meeting - Abstract No.: 3449 |
| 17/04/2023 15:15 | American Association for Cancer Research Meeting - New Drugs on the Horizon - Discovery of MRT-2359 |
| 16/03/2023 11:31 | Q4 2022 Earnings Release |
| 07/03/2023 15:30 | Cowen Health Care Conference |
| 21/02/2023 20:00 | Wells Fargo Targeted Protein Degradation (TPD) Virtual Summit |
| 14/02/2023 16:20 | SVB Securities Global Biopharma Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 15,1 - | 6,18 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -70,8 -69,0 -2.54% | -109 -104 -3.99% | -137 -93,4 -46.8% | -144 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -72,9 -72,0 -1.28% | -112 -109 -2.95% | -143 -131 -9.04% | -148 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -74,0 -73,4 -0.76% | -109 -108 -0.92% | -135 -123 -9.41% | -146 |
|
Net income Million USD | Released Forecast Spread | -35,9 | -74,0 -73,7 -0.41% | -109 -108 -0.44% | -135 -124 -9.53% | -144 |
|
EPS USD | Released Forecast Spread | -6,70 | -2,96 -2,61 -13.45% | -2,30 -2,28 -0.8% | -2,63 -2,42 -8.79% | -2,38 |
| Announcement Date | 04/06/21 | 29/03/22 | 16/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 15,1 - | 1,74 | 1,74 | 1,74 | 1,74 | 2,20 |
|
EBITDA Million USD | Released Forecast Spread | -31,4 -30,0 -4.66% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -23,4 -22,8 -2.39% | -24,3 -25,3 3.94% | -27,2 -21,8 -24.72% | -28,4 -27,7 -2.29% | -32,5 -30,2 -7.47% | -34,3 -33,3 -2.8% | -37,2 -34,7 -7.3% | -37,0 -37,7 1.92% | -34,9 -23,1 -51.22% | -35,4 | -36,7 | -38,2 | -39,6 | -44,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,4 -23,6 0.93% | -23,9 -25,7 6.87% | -26,5 -21,8 -21.36% | -27,3 -28,0 2.4% | -30,8 -29,6 -3.9% | -32,0 -32,9 2.73% | -35,0 -34,2 -2.41% | -34,7 -36,6 5.2% | -33,3 -21,6 -54.02% | -34,1 | -35,5 | -37,3 | -38,9 | -43,1 |
|
Net income Million USD | Released Forecast Spread | -23,4 -23,7 1.33% | -23,9 -25,7 6.73% | -26,5 -22,6 -17.15% | -27,3 -28,2 3.2% | -30,8 -30,2 -1.82% | -32,0 -33,3 3.74% | -35,2 -34,5 -1.85% | -34,9 -36,9 5.47% | -33,3 -21,6 -53.92% | -34,1 | -35,5 | -37,3 | -38,9 | -43,1 |
|
EPS USD | Released Forecast Spread | -0,11 -0,51 78.5% | -0,51 -0,54 5.57% | -0,57 -0,48 -18.42% | -0,58 -0,60 3.56% | -0,63 -0,62 -0.92% | -0,65 -0,68 4.5% | -0,71 -0,70 -1.89% | -0,70 -0,74 6.02% | -0,58 -0,39 -46.94% | -0,59 | -0,61 | -0,61 | -0,61 | -0,60 |
| Announcement Date | 29/03/22 | 11/05/22 | 11/08/22 | 10/11/22 | 16/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 14/03/24 | - | - | - | - | - |
More events
Past sector events for Monte Rosa Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GLUE Stock
- Calendar Monte Rosa Therapeutics, Inc.
